Literature DB >> 19614632

Utility of lead aVR for identifying the culprit lesion in acute myocardial infarction.

Jørgen Tobias Kühl1, Ronan M G Berg.   

Abstract

BACKGROUND: Lead aVR is a neglected, however, potentially useful tool in electrocardiography. Our aim was to evaluate its value in clinical practice, by reviewing existing literature regarding its utility for identifying the culprit lesion in acute myocardial infarction (AMI).
METHODS: Based on a systematic search strategy, 16 studies were assessed with the intent to pool data; diagnostic test rates were calculated as key results.
RESULTS: Five studies investigated if ST-segment elevation (STE) in aVR is valuable for the diagnosis of left main stem stenosis (LMS) in non-ST-segment AMI (NSTEMI). The studies were too heterogeneous to pool, but the individual studies all showed that STE in aVR has a high negative predictive value (NPV) for LMS. Six studies evaluated if STE in aVR is valuable for distinguishing proximal from distal lesions in the left anterior descending artery (LAD) in anterior ST-segment elevation AMI (STEMI). Pooled data showed a sensitivity of 47%, a specificity of 96%, a positive predicative value (PPV) of 91% and a NPV of 69%. Five studies examined if ST-segment depression (STD) in lead aVR is valuable for discerning lesions in the circumflex artery from those in the right coronary artery in inferior STEMI. Pooled data showed a sensitivity of 37%, a specificity of 86%, a PPV of 42%, and an NPV of 83%.
CONCLUSION: The absence of aVR STE appears to exclude LMS as the underlying cause in NSTEMI; in the context of anterior STEMI, its presence indicates a culprit lesion in the proximal segment of LAD.

Entities:  

Mesh:

Year:  2009        PMID: 19614632      PMCID: PMC6932033          DOI: 10.1111/j.1542-474X.2009.00300.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  41 in total

1.  Predictors of left main or three-vessel disease in patients who have acute coronary syndromes with non-ST-segment elevation.

Authors:  Masami Kosuge; Kazuo Kimura; Toshiyuki Ishikawa; Toshiaki Ebina; Tomoaki Shimizu; Kiyoshi Hibi; Noritaka Toda; Yoshio Tahara; Kengo Tsukahara; Masahiko Kanna; Jyunn Okuda; Naoki Nozawa; Hiroyuki Ozaki; Hideto Yano; Satoshi Umemura
Journal:  Am J Cardiol       Date:  2005-06-01       Impact factor: 2.778

2.  Correlation of electrocardiographic and pathologic findings in posterolateral infarction.

Authors:  G B MYERS; H A KLEIN; T HIRATZKA
Journal:  Am Heart J       Date:  1949-12       Impact factor: 4.749

3.  Value of lead aVR in the detection of significant left main coronary artery stenosis in acute coronary syndrome.

Authors:  Paweł Rostoff; Wiesława Piwowarska; Ewa Konduracka; Anna Libionka; Marzena Bobrowska-Juszczuk; Katarzyna Stopyra; Andrzej Gackowski; Aleksander Kubinyi; Bohdan Nessler; Danuta Mroczek-Czernecka
Journal:  Kardiol Pol       Date:  2005-02       Impact factor: 3.108

4.  Unstable angina: the significance of ST segment elevation or depression in patients without evidence of increased myocardial oxygen demand.

Authors:  S Sclarovsky; E Davidson; B Strasberg; R F Lewin; A Arditti; M Wurtzel; J Agmon
Journal:  Am Heart J       Date:  1986-09       Impact factor: 4.749

5.  [Usefulness of the electrocardiogram in predicting the occlusion site in acute anterior myocardial infarction with isolated disease of the left anterior descending coronary artery].

Authors:  Luis Martínez-Dolz; Miguel A Arnau; Luis Almenar; Joaquín Rueda; Ana Osa; Anastasio Quesada; Joaquín Osca; Esther Zorio; Miguel Palencia; Romualdo Cebolla
Journal:  Rev Esp Cardiol       Date:  2002-10       Impact factor: 4.753

6.  Correlation of angiographic findings and right (V1 to V3) versus left (V4 to V6) precordial ST-segment depression in inferior wall acute myocardial infarction.

Authors:  Y Birnbaum; G S Wagner; G I Barbash; K Gates; D A Criger; S Sclarovsky; R J Siegel; C B Granger; J S Reiner; A M Ross
Journal:  Am J Cardiol       Date:  1999-01-15       Impact factor: 2.778

7.  Value of ST elevation in lead III greater than lead II in inferior wall acute myocardial infarction for predicting in-hospital mortality and diagnosing right ventricular infarction.

Authors:  J Saw; C Davies; A Fung; J J Spinelli; J Jue
Journal:  Am J Cardiol       Date:  2001-02-15       Impact factor: 2.778

8.  Effect of coronary occlusion site on angiographic and clinical outcome in acute myocardial infarction patients treated with early coronary intervention.

Authors:  Peter Elsman; Arnoud W J van 't Hof; Jan C A Hoorntje; Menko-Jan de Boer; George F Borm; Harry Suryapranata; Jan Paul Ottervanger; A T Marcel Gosselink; Jan-Henk E Dambrink; Felix Zijlstra
Journal:  Am J Cardiol       Date:  2006-02-28       Impact factor: 2.778

9.  ST-segment depression in lead aVR: a useful predictor of impaired myocardial reperfusion in patients with inferior acute myocardial infarction.

Authors:  Masami Kosuge; Kazuo Kimura; Toshiyuki Ishikawa; Toshiaki Ebina; Kiyoshi Hibi; Noritaka Toda; Satoshi Umemura
Journal:  Chest       Date:  2005-08       Impact factor: 9.410

10.  Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction.

Authors:  Juhana Karha; Sabina A Murphy; Ajay J Kirtane; James A de Lemos; Julian M Aroesty; Christopher P Cannon; Elliott M Antman; Eugene Braunwald; C Michael Gibson
Journal:  Am J Cardiol       Date:  2003-10-15       Impact factor: 2.778

View more
  9 in total

Review 1.  Left main coronary artery disease: A review of the spectrum of noninvasive diagnostic modalities.

Authors:  Nishtha Sareen; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2015-10-20       Impact factor: 5.952

2.  Prognostic significance of T-wave amplitude in lead aVR in heart failure patients with narrow QRS complexes.

Authors:  Kentarou Okuda; Eiichi Watanabe; Kan Sano; Tomoharu Arakawa; Mayumi Yamamoto; Yoshihiro Sobue; Tatsushi Uchiyama; Yukio Ozaki
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-07       Impact factor: 1.468

3.  Exercise test predictors of severe coronary artery disease: Role of ST-segment elevation in lead aVR.

Authors:  Giulio Russo; Salvatore Emanuele Ravenna; Antonio De Vita; Cristina Aurigemma; Priscilla Lamendola; Gaetano Antonio Lanza; Filippo Crea
Journal:  Clin Cardiol       Date:  2016-11-02       Impact factor: 2.882

4.  The Value of Lead aVR ST Segment Changes in Localizing Culprit Lesion in Acute Inferior Myocardial Infarction and Its Prognostic Impact.

Authors:  Leili Pourafkari; Arezou Tajlil; Seyed Sajjad Mahmoudi; Samad Ghaffari
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-11-02       Impact factor: 1.468

5.  Acute myocardial infarction due to left main coronary artery disease in men and women: does ST-segment elevation matter?

Authors:  Marcin Sadowski; Wojciech Gutkowski; Grzegorz Raczyński; Agnieszka Janion-Sadowska; Marek Gierlotka; Lech Poloński
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

6.  Combining electrocardiographic criteria for predicting acute total left main coronary artery occlusion.

Authors:  Chunwei Liu; Fan Yang; Yuecheng Hu; Jingxia Zhang; Ximing Li; Zhigang Guo; Yin Liu; Hongliang Cong
Journal:  Front Cardiovasc Med       Date:  2022-08-11

7.  Acute myocardial infarction and syncope in an 18-year-old athlete with an abnormal origin of the left coronary artery: a case report.

Authors:  Ronan Mg Berg; Bente Brendorp; Thomas Kristensen; Morten Helvind; Steffen Helqvist
Journal:  Cases J       Date:  2009-09-10

8.  ST Segment Elevation in aVR: Clinical Significance in Acute Coronary Syndrome.

Authors:  Antoine Kossaify
Journal:  Clin Med Insights Case Rep       Date:  2013-03-21

Review 9.  Classical electrocardiographic clues for left main coronary artery disease.

Authors:  Fatih Sen; Ozcan Ozeke; Ozgur Kirbas; Cengiz Burak; Habibe Kafes; Bahar Tekin Tak; Umran Ozdamar; Kadir Ocak; Serkan Topaloglu; Dursun Aras
Journal:  Indian Heart J       Date:  2016-04-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.